Pacira BioSciences Inc.
PCRX | NASDAQ
$24.79
+$0.68 (+2.82%)
Sep 22, 2026, 11:31 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 746.16M | 734.86M | 726.41M | 716.79M | 705.85M | 702.77M | 700.97M | 694.96M | 690.31M | 681.75M | 674.98M | 665.69M | 669.23M | 669.17M | 666.82M | 654.06M | 614.32M | 580.5M | 541.53M | 513.31M | 503.08M | 442.99M |
Cost of Revenue | 155.15M | 151.86M | 149.75M | 149.34M | 153.92M | 157.32M | 170.43M | 178.23M | 179.12M | 183.07M | 184.67M | 198.89M | 209.82M | 212.24M | 199.3M | 176.39M | 160.36M | 144.98M | 140.26M | 136.55M | 131.89M | 118.94M |
Gross Profit | 591.01M | 583.01M | 576.66M | 567.46M | 551.93M | 545.45M | 530.54M | 516.72M | 511.19M | 498.69M | 490.31M | 466.8M | 459.41M | 456.93M | 467.53M | 477.68M | 453.96M | 435.52M | 401.28M | 376.77M | 371.19M | 324.05M |
Operating Income | 18.45M | 22.68M | 20.04M | 41.56M | -104.33M | -84.59M | -73.37M | -64.91M | 92.34M | 103.98M | 87.68M | 44.61M | 48.18M | 39.54M | 60.02M | 74.13M | 84.27M | 87.88M | 89.92M | 104.5M | 90.68M | 48.69M |
Interest Income | 14.7M | 17.77M | 22.73M | 25.99M | 22.94M | 22.68M | 19.69M | 17.56M | 14.84M | 12.21M | 11.44M | 10.8M | 9.27M | 7.41M | 4.54M | 1.84M | 779K | 751K | 895K | 1.51M | 2.36M | 3.46M |
Pretax Income | 17.65M | 13.17M | 16.87M | 41.83M | -106.55M | -68.04M | -63.11M | -54.91M | 100.55M | 101.82M | 61.7M | 9.91M | -4.62M | -20.47M | 13.3M | 25.17M | 47.33M | 50.98M | 56.41M | 75.3M | 57.22M | 24.26M |
Net Income | 14.64M | 5.14M | 7.03M | 21.44M | -127.46M | -103.73M | -99.56M | -90.73M | 63.59M | 70.47M | 41.96M | 6.98M | -4.57M | -10.46M | 15.91M | 20.88M | 39.23M | 38.44M | 41.98M | 61.63M | 174.08M | 147.73M |
Selling & General & Admin | 379.16M | 375.93M | 368.76M | 346.77M | 329.3M | 308.85M | 294.1M | 280.29M | 273.9M | 270.62M | 269.44M | 267.61M | 260.95M | 261.1M | 254.52M | 241.75M | 228.32M | 214.13M | 198.39M | 200.02M | 204.73M | 197.26M |
Research & Development | 121.73M | 119.69M | 116.96M | 103.41M | 96.54M | 88.68M | 81.58M | 77.14M | 78.87M | 77.36M | 76.26M | 74.3M | 72.87M | 80.33M | 84.8M | 82.81M | 74.98M | 61.27M | 55.54M | 55.36M | 58.43M | 59.48M |
Other Expenses | 71.67M | 64.71M | 70.9M | 75.73M | 230.42M | 232.52M | 228.23M | 224.2M | 66.08M | 46.73M | 56.94M | 80.27M | 77.41M | 75.96M | 68.19M | 78.99M | 66.39M | 72.24M | 57.42M | 16.89M | 17.34M | 18.62M |
Operating Expenses | 572.57M | 560.33M | 556.62M | 525.9M | 656.26M | 630.05M | 603.91M | 581.63M | 418.85M | 394.71M | 402.63M | 422.18M | 411.23M | 417.39M | 407.5M | 403.55M | 369.69M | 347.64M | 311.35M | 272.27M | 280.51M | 275.35M |
Interest Expense | 13.83M | 14.9M | 16.3M | 16.76M | 17.8M | 16.22M | 14.96M | 14.51M | 13.29M | 14.03M | 20.31M | 27.96M | 34.35M | 39.32M | 39.98M | 39.36M | 36.84M | 35.03M | 31.75M | 28.39M | 28.19M | 26.62M |
Selling & Marketing Expenses | 178.25M | 229.21M | 226.62M | 215.35M | 200.07M | 188.15M | 172.02M | 157.41M | 152.48M | 150.9M | 153.04M | 153.3M | 148.74M | 148.14M | 145M | 138.36M | 130.96M | 122.36M | 111.02M | 113.86M | 120.78M | 117.87M |
Cost & Expenses | 727.72M | 712.19M | 706.37M | 675.24M | 810.18M | 787.37M | 774.34M | 759.86M | 597.97M | 577.78M | 587.3M | 621.08M | 621.05M | 629.63M | 606.8M | 579.93M | 530.05M | 492.62M | 451.61M | 408.82M | 412.39M | 394.3M |
Income Tax Expense | 3.01M | 8.03M | 9.84M | 20.39M | 20.91M | 35.69M | 36.45M | 35.82M | 36.95M | 31.35M | 19.75M | 2.93M | -51K | -10.01M | -2.61M | 4.29M | 8.1M | 12.54M | 14.43M | 13.67M | -116.87M | -123.48M |
Shares Outstanding (Basic) | 39.46M | 40.46M | 42.49M | 44.04M | 45.46M | 46.28M | 46.17M | 46.13M | 46.17M | 46.5M | 46.44M | 46.42M | 46.09M | 45.95M | 45.88M | 45.83M | 45.5M | 44.87M | 44.59M | 44.48M | 44.15M | 43.83M |
Shares Outstanding (Diluted) | 40.3M | 40.91M | 42.98M | 44.46M | 45.46M | 46.53M | 49.04M | 46.13M | 50.54M | 52.19M | 52.06M | 52.07M | 52.05M | 45.95M | 45.88M | 45.83M | 52.48M | 46.44M | 44.59M | 45.46M | 45.59M | 45.97M |
EPS (Basic) | 0.35 | 0.12 | 0.15 | 0.46 | -2.77 | -2.25 | -2.16 | -1.97 | 1.37 | 1.52 | 0.90 | 0.14 | -0.11 | -0.23 | 0.35 | 0.45 | 0.87 | 0.86 | 0.95 | 1.40 | 4.03 | 3.43 |
EPS (Diluted) | 0.35 | 0.12 | 0.15 | 0.45 | -2.78 | -2.28 | -2.19 | -2.05 | 1.29 | 1.41 | 0.79 | 0.09 | -0.16 | -0.27 | 0.31 | 0.41 | 0.82 | 0.84 | 0.92 | 1.36 | 3.91 | 3.32 |
EBITDA | 114.76M | 118.4M | 122.5M | 147.82M | -1.3M | 28.03M | 29.12M | 33.42M | 185.99M | 187.51M | 154.59M | 121.61M | 115.02M | 105.77M | 140.38M | 134.96M | 140.37M | 126.45M | 113.95M | 121.61M | 102.67M | 68.45M |
EBIT | 29.6M | 27.22M | 31.48M | 56.9M | -91.29M | -53.5M | -49.67M | -42.6M | 111.79M | 113.11M | 79.01M | 34.12M | 25.76M | 14.7M | 48.88M | 60.8M | 80.67M | 82.72M | 85.4M | 101.07M | 82.82M | 48.51M |
Depreciation & Amortization | 85.16M | 91.19M | 91.02M | 90.92M | 89.99M | 81.53M | 78.79M | 76.03M | 74.21M | 74.4M | 75.57M | 87.5M | 89.26M | 91.07M | 91.5M | 74.17M | 59.7M | 43.73M | 28.55M | 20.54M | 19.85M | 19.94M |
Add to Watchlist
Select watchlists to add or remove PCRX